Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.
Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.
Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.
Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.
交易结束：到达目标
相关出版物
免责声明
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
免责声明
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.